These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31731794)

  • 1. Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets.
    Tan HL; Choo A
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of pluripotent stem cells and their derivatives: current status and future perspectives.
    Pendse S; Vaidya A; Kale V
    Regen Med; 2022 Sep; 17(9):677-690. PubMed ID: 35703035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Differentiation Potential of Already-Established Pluripotent Stem Cells.
    González-Martínez J; Malumbres M
    Methods Mol Biol; 2022; 2454():95-107. PubMed ID: 34128208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical potentials of human pluripotent stem cells.
    Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
    Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation.
    Park J; Lee DG; Lee NG; Kwon MG; Son YS; Son MY; Bae KH; Lee J; Park JG; Lee NK; Min JK
    BMB Rep; 2022 Mar; 55(3):142-147. PubMed ID: 34674794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of genomic stability maintenancein pluripotent stem cells.
    Zheng P
    Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(6):858-863. PubMed ID: 35713312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells as a novel tool for drug screening and treatment of degenerative diseases.
    Zuba-Surma EK; Wojakowski W; Madeja Z; Ratajczak MZ
    Curr Pharm Des; 2012; 18(18):2644-56. PubMed ID: 22512442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The march of pluripotent stem cells in cardiovascular regenerative medicine.
    Abou-Saleh H; Zouein FA; El-Yazbi A; Sanoudou D; Raynaud C; Rao C; Pintus G; Dehaini H; Eid AH
    Stem Cell Res Ther; 2018 Jul; 9(1):201. PubMed ID: 30053890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation and application of pluripotent stem cells for regenerative medicine.
    Wang J; Zhou Q
    Sci China Life Sci; 2016 Jun; 59(6):576-83. PubMed ID: 27225262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic regulation in pluripotent stem cells.
    Diamante L; Martello G
    Curr Opin Genet Dev; 2022 Aug; 75():101923. PubMed ID: 35691147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent stem cells: the last 10 years.
    Kimbrel EA; Lanza R
    Regen Med; 2016 Dec; 11(8):831-847. PubMed ID: 27908220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism in Human Pluripotent Stem Cells and Cardiomyocytes for Regenerative Therapy.
    Umei TC; Tohyama S
    Keio J Med; 2022 Sep; 71(3):55-61. PubMed ID: 35082186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes.
    Tanosaki S; Tohyama S; Kishino Y; Fujita J; Fukuda K
    Inflamm Regen; 2021 Feb; 41(1):5. PubMed ID: 33526069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo surveillance and elimination of teratoma-forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2.
    Tan HL; Tan BZ; Goh WXT; Cua S; Choo A
    Biotechnol Bioeng; 2019 Nov; 116(11):2996-3005. PubMed ID: 31388993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells.
    Gopalakrishna-Pillai S; Iverson LE
    PLoS One; 2011; 6(6):e20663. PubMed ID: 21698279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming.
    Nishimura K; Fukuda A; Hisatake K
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.